<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00850014958015</udiDi>
    <basicUdiDi>0850014958CNSPFVZ</basicUdiDi>
    <tradeName>Contour Neurovascular System</tradeName>
    <deviceName>Contour Neurovascular System Product Family (CNSPF)</deviceName>
    <manufacturerName>Cerus Endovascular, Ltd.</manufacturerName>
    <manufacturerSrn>GB-MF-000008548</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C010404020299</emdnCode>
    <emdnDescription>NEUROVASCULAR EMBOLISATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CNS011-15</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-23T14:49:58.103Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850014958039</udiDi>
    <basicUdiDi>0850014958CNSPFVZ</basicUdiDi>
    <tradeName>Contour 021</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cerus Endovascular, Ltd.</manufacturerName>
    <manufacturerSrn>GB-MF-000008548</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C010404020299</emdnCode>
    <emdnDescription>NEUROVASCULAR EMBOLISATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CNS21005-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-23T14:48:09.875Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850014958053</udiDi>
    <basicUdiDi>0850014958CNSPFVZ</basicUdiDi>
    <tradeName>Contour 021</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cerus Endovascular, Ltd.</manufacturerName>
    <manufacturerSrn>GB-MF-000008548</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C010404020299</emdnCode>
    <emdnDescription>NEUROVASCULAR EMBOLISATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CNS21007-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-23T14:48:09.788Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850014958077</udiDi>
    <basicUdiDi>0850014958CNSPFVZ</basicUdiDi>
    <tradeName>Contour 021</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cerus Endovascular, Ltd.</manufacturerName>
    <manufacturerSrn>GB-MF-000008548</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C010404020299</emdnCode>
    <emdnDescription>NEUROVASCULAR EMBOLISATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CNS21009-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-23T14:48:09.732Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850014958145</udiDi>
    <basicUdiDi>0850014958CNSPFVZ</basicUdiDi>
    <tradeName>Neqstent 021</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cerus Endovascular, Ltd.</manufacturerName>
    <manufacturerSrn>GB-MF-000008548</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C010404020299</emdnCode>
    <emdnDescription>NEUROVASCULAR EMBOLISATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NQS21407-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-23T14:48:09.631Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850014958169</udiDi>
    <basicUdiDi>0850014958CNSPFVZ</basicUdiDi>
    <tradeName>Neqstent 021</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cerus Endovascular, Ltd.</manufacturerName>
    <manufacturerSrn>GB-MF-000008548</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C010404020299</emdnCode>
    <emdnDescription>NEUROVASCULAR EMBOLISATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NQS21409-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-23T14:48:09.526Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850014958183</udiDi>
    <basicUdiDi>0850014958CNSPFVZ</basicUdiDi>
    <tradeName>Neqstent 021</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cerus Endovascular, Ltd.</manufacturerName>
    <manufacturerSrn>GB-MF-000008548</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C010404020299</emdnCode>
    <emdnDescription>NEUROVASCULAR EMBOLISATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NQS21411-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-23T14:48:09.404Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850014958237</udiDi>
    <basicUdiDi>0850014958CNSPFVZ</basicUdiDi>
    <tradeName>Contour Neurovascular System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cerus Endovascular, Ltd.</manufacturerName>
    <manufacturerSrn>GB-MF-000008548</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C010404020299</emdnCode>
    <emdnDescription>NEUROVASCULAR EMBOLISATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CNS014-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-23T14:48:09.280Z</lastUpdated>
  </row>
  <row>
    <udiDi>00850014958251</udiDi>
    <basicUdiDi>0850014958CNSPFVZ</basicUdiDi>
    <tradeName>Neqstent</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Cerus Endovascular, Ltd.</manufacturerName>
    <manufacturerSrn>GB-MF-000008548</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C010404020299</emdnCode>
    <emdnDescription>NEUROVASCULAR EMBOLISATION DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NQS414-15</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-23T14:48:08.963Z</lastUpdated>
  </row>
</eudamedExport>